KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Interest & Investment Income: 2018-2025

Historic Interest & Investment Income for Castle Biosciences (CSTL) over the last 8 years, with Sep 2025 value amounting to $2.8 million.

  • Castle Biosciences' Interest & Investment Income fell 16.77% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 million, marking a year-over-year decrease of 3.28%. This contributed to the annual value of $12.9 million for FY2024, which is 21.59% up from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Interest & Investment Income is $2.8 million, which was down 3.77% from $2.9 million recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Interest & Investment Income registered a high of $3.4 million during Q3 2024, and its lowest value of $4,000 during Q1 2021.
  • In the last 3 years, Castle Biosciences' Interest & Investment Income had a median value of $3.0 million in 2024 and averaged $2.9 million.
  • In the last 5 years, Castle Biosciences' Interest & Investment Income tumbled by 98.66% in 2021 and then skyrocketed by 13,282.35% in 2022.
  • Over the past 5 years, Castle Biosciences' Interest & Investment Income (Quarterly) stood at $17,000 in 2021, then surged by 13,282.35% to $2.3 million in 2022, then skyrocketed by 37.10% to $3.1 million in 2023, then climbed by 8.11% to $3.4 million in 2024, then decreased by 16.77% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $2.9 million for Q2 2025, and $3.1 million during Q1 2025.